Health-related quality of life after salvage high-intensity focused ultrasound (HIFU) treatment for locally radiorecurrent prostate cancer

International Journal of Urology

Volumn 18, Issue 9, 2011, Pages 646-651

  Berge, Viktor ^a   Baco, Eduard ^a   Dahl, Alv A ^a   Karlsen, Steinar Johan ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Health related quality of life; High intensity focused ultrasound (HIFU); Los Angeles Prostate Cancer Index (UCLA PCI); Radiorecurrent prostate cancer; Salvage; University of California

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ASSESSMENT; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HEALTH STATUS; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MENTAL HEALTH; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RADIORECURRENT PROSTATE CANCER; SALVAGE THERAPY; SEXUAL FUNCTION; URINARY TRACT FUNCTION;

AGED; FOLLOW-UP STUDIES; HEALTH STATUS; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; SALVAGE THERAPY; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TREATMENT OUTCOME; URINATION DISORDERS;

EID: 80051883847     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2011.02815.x     Document Type: Article

References (20)

1. Kuban DA, Thames HD, Levy LB etal. Long-term multiinstitutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. Int. J. Radiat. Oncol. Biol. Phys. 2003; 57: 915-28.
2. Zelefsky MJ, Reuter VE, Fuks Z, Scardino P, Shippy A. Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer. J. Urol. 2008; 179: 1368-73.
3. Kimura M, Mouraviev V, Tsivian M etal. Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy. BJU Int. 2009; 105: 191-201.
4. Chalasani V, Martinez CH, Lim D, Chin J. Salvage HIFU for recurrent prostate cancer after radiotherapy. Prostate Cancer Prostatic Dis. 2009; 12: 124-9.
5. Gelet A, Chapelon JY, Bouvier R etal. Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer. J. Endourol. 2000; 14: 519-28.
6. Berge V, Baco E, Karlsen SJ. A prospective study of salvage high-intensity focussed ultrasound (HIFU) for locally radiorecurrent prostate cancer. Early results. Scand. J. Urol. Nephrol. 2010; 44: 223-7.
7. Eton DT, Lepore SJ. Prostate cancer and health-related quality of life: a review of the literature. Psychooncology 2002; 11: 307-26.
8. Murat F-J, Poissonnier L, Rabilloud M etal. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. Eur. Urol. 2009; 55: 640-9.
9. Perrotte P, Litwin MS, McGuire EJ, Scott SM, von Eschenbach AC, Pisters LL. Quality of life after salvage cryotherapy: the impact of treatment parameters. J. Urol. 1999; 162: 398-402.
10. Anastasiadis AG, Sachdev R, Salomon L etal. Comparison of health-related quality of life and prostate-associated symptoms after primary and salvage cryotherapy for prostate cancer. J. Cancer Res. Clin. Oncol. 2003; 129: 676-82.
11. Sanderson KM, Penson DF, Cai J etal. Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer. J. Urol. 2006; 176: 2025-32.
12. Litwin MS, Hays RD, Fink A etal. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995; 273: 129-35.
13. D'Amico AV, Whittington R, Malkowicz SB etal. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-74.
14. Ware JE Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med. Care 1996; 13: 220-33.
15. Gandek B, Ware JE, Aaronson NK etal. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J. Clin. Epidemiol. 1998; 51: 1171-8.
16. Hougen HC, Gløboden MA. [The Survey of Living Conditions] (in Danish). 2002. [Cited 10 May 2011.] Available from URL.
17. Sloan JA, Vargas-Chanes D, Kamath CC etal. Detecting worms, ducks, and elephants: a simple approach for defining clinically relevant effects in quality-of-life measures. J. Cancer Integr. Med. 2003; 1: 41-7.
18. Shoji S, Nakano M, Nagata Y, Usui Y, Terachi T, Uchida T. Quality of life following high-intensity focused ultrasound for the treatment of localized prostate cancer: a prospective study. Int. J. Urol. 2010; 17: 715-19.
19. Stephenson AJ, Scardino PT, Bianco FJ, DiBlasio CJ, Fearn PA, Eastham JA. Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J. Urol. 2004; 172: 2239-43.
20. Heidenreich A, Richter S, Thüer D, Pfister D. Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy. Eur. Urol. 2010; 57: 437-43.